Introduction {#s1}
============

The substantial improvement in the methodology of protein structure determination is reflected by an exponential increase in the number of structures deposited in the Protein Data Bank (PDB) [@pone.0039993-Berman1]. Functional annotation and mechanistic interpretations of several of these structural models, however, remains a significant hurdle. Information on protein dynamics and conformational variations is an important input for mechanistic interpretation. While this information is experimentally captured by Nuclear Magnetic Resonance (NMR) spectroscopy methods, structural models determined by X-Ray crystallography have to be further subjected to intensive computational methods for dynamic information. *In silico* strategies to obtain dynamic information are both time-consuming and have an inherent limitation as they do not explicitly incorporate experimental errors and artifacts induced by experimental conditions. While experimental errors can, in principle, be incorporated in computational simulations, these require access to unprocessed experimental data that is not currently freely available to analyze. Experimental conditions, on the other hand, are available either with the structural coordinates or in manuscripts that describe macromolecular structures in more detail. An examination of protein structural models along with experimental conditions could potentially aid in de-convoluting conformational selection induced during the structure determination process.

It is increasingly apparent that a single structural model of a protein is likely to be incomplete in its information content- given that it provides a single representation of several flexible segments and alternative conformations. It is thus imperative to de-convolute the dynamics and alternate conformations from a structural model to obtain a more functionally relevant model of a biological molecule. *In silico* strategies, such as Molecular Dynamics (MD) simulations, from-CONstraints-to-COORDinates (CONCOORD) analysis or more often, normal modes analysis are employed to extrapolate dynamic motions of a protein from a single experimentally determined structural model. These techniques, however, do not explicitly incorporate features such as experimental conditions or the propensity of a protein stretch to adopt conformations other than that modeled by the experimenter. The large number of structures present in the protein data bank suggests that a systematic analysis of these parameters could form a potentially useful source of information to interpret protein structures solved at high resolution. A reliable de-convolution of dynamic information that accounts for experimental artifacts could also aid in structure-based functional annotation. Indeed, a protocol that incorporates dynamic information from small protein domains to predict structural variations in large macromolecular complexes could provide valuable mechanistic information. An essential requirement towards these goals is an estimate of the influence of experimental parameters in the selection of alternate conformations that were modeled in X-Ray crystal structures or were retained in an NMR derived structural ensemble. In this study, we examine differences between structural models that share high sequence similarity to obtain an estimate of context-dependent remodeling or conformational selection. The dataset for this analysis comprised structural models derived by X-Ray and NMR methods encompassing five Structural Classification of Proteins (SCOP) classes. Multi-protein complexes and structures of peptides determined independently and as a part of large proteins were included in this analysis. Structural variations within this data-set were examined for intrinsic (sequence-based) features as well as external (experimental) parameters. This analysis highlights structural differences and provides a dataset to test *in silico* methods to extract dynamic properties of proteins while explicitly incorporating the influence of experimental parameters on structural models.

Results {#s2}
=======

A mechanistic interpretation of the function and regulation of a protein crucially depends on information on the dynamic motions and alternate conformations that could be adopted by its structure. An estimate of the extent of conformational variation in structural models of proteins that share high sequence similarity can provide vital inputs to incorporate alternate conformations for a given molecular model. This data, however, requires additional information to distinguish between inherent flexibility vis-à-vis structural variations that can be explained by experimental conditions. Experimental context in this case includes factors that influence conformation by virtue of interactions between polypeptide fragments, concentration dependent and osmolyte-induced effects as well as ligand interactions. A representative dataset of protein structural models was collated to examine the effect of experimental conditions on conformational selection.

Dataset of Proteins for Comparative Analysis {#s2a}
--------------------------------------------

The dataset for this analysis includes high resolution crystal structures, NMR structural ensembles, protein structures that were determined in both the free-state (apo) as well as complexes with ligands or as a component of a large macromolecular complex. A pictorial description of this dataset is shown in [Figure 1](#pone-0039993-g001){ref-type="fig"}. This dataset incorporates all SCOP classes of proteins except membrane proteins. As there were no suitable NMR entries for multi-domain proteins and very few structures in the category of membrane and cell surface proteins, these classes were not included in this study. Protein structures were retrieved from the PDB based on folds, super-families and families which yielded a total of 1086 folds, 1777 super-families and 3464 families [@pone.0039993-LoConte1]. Further pruning based on sequence and structural criteria resulted in 233 structures spread across 5 classes of proteins viz., α, β, α+β, α/β and small proteins. A sub-set of 31 protein pairs that shared high sequence similarity but showed prominent differences in conformation were chosen for detailed analysis ([Table 1](#pone-0039993-t001){ref-type="table"}, [Table S1](#pone.0039993.s002){ref-type="supplementary-material"}). Information on disordered proteins was obtained from the DISPROT database [@pone.0039993-Sickmeier1]. From this dataset of 183 protein-protein and 82 protein-nucleic acid complexes, 90 protein complexes and 35 protein-nucleic acid complexes were selected for further analysis. We found 52 protein-protein complexes and 20 protein-nucleic acid complexes that showed substantial variation in their structures between the free form, as a part of larger complexes or in some cases between different multi-protein complexes. Although peptides are not a true SCOP class, these were also included (110 structures) to examine the influence of context on structure. 45 amongst these peptide structures had an equivalent stretch (sequence identity \>80%) in a larger protein ([Figure 1B](#pone-0039993-g001){ref-type="fig"}). The final dataset of protein complexes and peptide structures that show conformational variation are listed in [Tables 2](#pone-0039993-t002){ref-type="table"} and [3](#pone-0039993-t003){ref-type="table"}.

![Summary of the dataset of molecular models examined for structural variations and conformational selection by experimental methods.\
(**A**) The initial dataset of proteins was compiled for a representative sampling of folds and families. After selecting protein-structural pairs based on experimental and sequence criteria, the dataset for analysis included 31 different protein pairs across five different structural classes. (**B**) Bar diagrams represent the protein-protein, protein-nucleic acid complexes and peptides used in this study. Dark blue bars in all the classes represent the initial selection from a set of 183 protein-protein complexes, 82 protein-nucleic acid complexes and 110 peptide structures. The final composition of this dataset (shown here in gray and light blue bars) is based on the sequence and structural criteria described in the methods section of this manuscript.](pone.0039993.g001){#pone-0039993-g001}

10.1371/journal.pone.0039993.t001

###### Comparison between X-ray and NMR structures in different classes of proteins.
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  α-class of proteins                                                                                                                                                                           
  ----------------------------- ------ --------------------------------------- ---------------------------------------------------------------------------------------------------------------- -------------------------
  1K96/1A03                       90             42∶51 - LTIGSKLQDA                                         α-helix in crystal structure; Unstructured in solution                                       α-helix
  1GU2/1E8E                      100              28∶36 - ITDGKIFFN                                         α-helix in crystal structure; Unstructured in solution                                   β-strand +Coil
                                                   48∶54 - ACASCHT                                      α-helix in crystal structure; Hydrogen bonded turn in solution                               β-strand +Coil
                                                  61∶70- GKNIVTGKEI                                     β-strand and turn in crystal structure; β- bridge in solution                                β-strand +Coil
  1NZN/1PC2                      78.1            5∶13 - EAVLNELVSVED                                        α-helix in crystal structure; Unstructured in solution                                       α-helix
  1I27/1NHA                      86.6             478∶483- QTKKTGL                                          α-helix in crystal structure; Unstructured in solution                                       α-helix
  1OMR/1JSA                      100            97∶109- TNQKLEWAFSLY                                3~10~-helix and α-helix in crystal structure; Unstructured in solution                               α-helix
  1HH5/1F22                      100            17∶29 - HKAHAEKLGCDAC                             α-helix and 3~10~-helix in crystal structure; α-helix and coil in solution                              Coil
                                                   61∶66 - KCGGCH                                           α-helix in crystal structure; Unstructured in solution                                   Coil + β-strand
  1H0A/1INZ                      88.9           3∶15 - TSSLRRQMKNIVH                                        α-helix in crystal structure; Unstructured in solution                                       α-helix
  5P2P/1SFV                      91.9               18∶22 - PLMDF                                           α-helix in crystal structure; Unstructured in solution                                        Coil
                                                    113∶115- KEH                                     3~10~-helix and β-bridge in crystal structure; β-bridge in solution                                   ND
                                                    120∶123- TKKY                                           α-helix in crystal structure; Unstructured in solution                                         ND
  **β-class of proteins**                                                                                                                                                                       
  1OPA/1B4M                      100              27∶35 - FATRKIAVR                                         α-helix in crystal structure; Unstructured in solution                                      α -helix
                                                  5∶14 - NGTWEMESNE                               β-strand in crystal structure; Small β-strand and unstructuredin solution                             β-strand
                                                    72∶75 - EHTK                                       β-strand and turn in crystal structure; unstructured in solution                                    ND
  1XCA/1BLR                      99.3            28∶38 - LRKIAVAAASK                                        α-helix in crystal structure; Unstructured in solution                                      α -helix
                                                127∶137- DVVCTRVYVRE                                  β-strand in crystal structure; Small β-strand and turn in solution                                β-strand
                                                   60∶66 - TTEINFK                                         β-strand in crystal structure, unstructured in solution                                      β-strand
  2GIM/1FA4                      99.1               2∶7 - ETYTVKL                                          β-strand in crystal structure; Unstructured in solution                                      β-strand
                                                  52∶60 - SADLAKSLS                                         α-helix in crystal structure; Unstructured in solution                                       α-helix
                                                   83∶89 - GEYTFYC                                         β-strand in crystal structure; Unstructured in solution                                      β-strand
                                                   90∶96 - EPHRGAG                                          α-helix in crystal structure; Unstructured in solution                                        Coil
  1SPD/1RK7                      96.1             41∶48 - GLHGFHVH                                         β-strand in crystal structure; Unstructured in solution                                      β-strand
                                                    85∶89 - NVTA                                           β-strand in crystal structure; Unstructured in solution                                         ND
                                                     97∶99 - VSI                                             β-strand in crystal structure; β-strand in solution                                           ND
                                                   116∶120- TLVVH                                          β-strand in crystal structure; Unstructured in solution                                         ND
                                                   54∶60 - TAGCTSA                                           Turn in crystal structure; Unstructured in solution                                          Coil
                                                   132∶137- EESTKT                                        α-helix in crystal structure; Hydrogen bonded in solution                                       Coil
  1J2A/1CLH                      99.4             38∶45 - SGFYNNTT                                        Hydrogen bonded turn and β-sheet; Unstructured in solution                                      Coil
                                                 48∶57 - RVIPGFMIQG                           Anti-parallel β-sheet in crystal structure; Short anti-parallelβ-sheet in solution                  Anti-parallel β-sheet
                                                    77∶80 - ADNG                                          3~10~-helix in crystal structure; Unstructured in solution                                       ND
  1IAZ/1KD6                      99.2              8∶15 - VIDGSALS                                   β-strand and 3~10~-helix in crystal; Hydrogen bonded turnin solution                            β-strand + Coil
                                                129∶138 - DQRMYEELYY                        α-helix in crystal structure; Short α-helix followed by unstructuredregion in solution                       α-helix
  1WHO/1BMW                      100                 4∶8 - VTFTV                                           β-strand in crystal structure; Unstructured in solution                                         ND
                                                  16∶23 - HLAVLVKY                             β-strand in crystal structure; Isolated β-bridge mostly unstructuredin solution                          β-strand
                                                   28∶34 - MAEVELR                               β-strand in crystal structure; Small β-strand mostly unstructuredin solution                           β-strand
                                                    51∶55 - VWTFD                                   β-strand in crystal structure; Unstructured, isolated β-strand,bridge                                  ND
                                                   64∶70 - FNFRFLT                                      β-strand in crystal structure; Unstructured, isolated β-bridge                                  β-strand
                                                  75∶82 - KNVFDDVV                            β-strand in crystal structure; Unstructured, isolated β-strand,bridge in solution                      β-strand+ Coil
  **α + β class of proteins**                                                                                                                                                                   
  2SAK/1SSN                       89             38∶48 - ELLSPHYVEFP                                        β-strand in X-ray structure; Unstructured in solution                                    Coil+ β-strand
                                                   76∶81 - FRVVEL                                          β-strand in crystal structure; Unstructured in solution                                      β-strand
  1QVE/1HPW                      96.1     31∶55 - AQLSEAMTLASGLKTKVSDIFSQDG                   Two helices connected through a turn in crystal structure;Single helix in solution                  α-helix-coil-α-helix
                                                 78∶88 - VAKVTTGGTA                                        β-strand in crystal structure; Unstructured in solution                                      β-strand
  1C44/1QND                      97.6              90∶95 - PQSAFF                                α-helix-coil-β-strand in crystal structure; Hydrogen bondedturn in solution                      α-helix-coil-β-strand
                                                    99∶102- LKIT                                           β-strand in crystal structure; Unstructured in solution                                         ND
                                                  105∶112- MGLAMKLQ                                     α-helix in crystal structure; Hydrogen bonded turn in solution                                   α-helix
  3IL8/1IKM                      100             19∶28 - PKFIKELRVI                        3~10~-helix followed by β-strand in crystal structure; β-bridge andβ-strand in solution                   Coil + β-strand
                                                   66∶72 - LKRAENS                                          α-helix in crystal structure; Unstructured in solution                                       α-helix
  1TN3/1RJH                      86.1            58∶68 - MKCFLAFTQTK                                       β-strand in crystal structure; Unstructured in solution                                   β-strand + Coil
  **α/β class of proteins**                                                                                                                                                                     
  1RRF/1U81                      90.6              18∶24 - MRILMVG                            β-strand in crystal structure; Unstructured, isolated β-strand,bridge in solution                    α-helix + β-strand
                                                   43∶48 - VTTIPT                                 β-strand in crystal structure; Unstructured, isolated β-bridgein solution                             β-strand
                                               76∶92- PLWRFQNTQGLIFVV           3~10~-helix, unstructured followed by β-strand in crystal structure;α-helical followed by β-strand in solution   α-helix-coil- β-strand
                                               99∶113- RVNEAREELMRMLAE                             α-helix in crystal structure; Unstructured, short helix, turnin solution                              α-helix
  1EZ9/1EZO                      99.7               145∶147- SAL                                           β-strand in crystal structure; unstructured in solution                                         ND
                                                   222∶227- TAMTIN                                         β-strand in crystal structure; unstructured in solution                                         ND
                                                 258∶266- FVGVLSAGI                                        β-strand in crystal structure; unstructured in solution                                      β-strand
                                                  305∶311- KSYEEEL                                      α-helix in crystal structure; turn and short helix in solution                                   α-helix
  5P21/1CRP                      99.4   37∶46 - EDSYRKQVVI 49∶58 - ETCLLDILDT                    β-strand-turn- β-strand in crystal structure; Shortened β-strandin solution                     β-strand-coil- β-strand
  **Small proteins**                                                                                                                                                                            
  1PSP/1PCP                      100                5∶10 - ACRCSR                                               α-helix in crystal structure; turn in solution                                          β-strand
                                                     13∶15- PKN                                           3~10~-helix in crystal structure; unstructured in solution                                       ND
                                                    55∶59 - SEECV                                             3~10~-helix in crystal structure; turn in solution                                           ND
                                                    61∶64 - QVSA                                              3~10~-helix in crystal structure; turn in solution                                           ND
  1NTN/1W6B                      97.3                50∶52 - ESY                                             Turn in crystal structure; unstructured in solution                                           ND
                                                   62∶68 - NCNPHPK                                        Mix of turn in crystal structure; 3~10~-helix in solution                                       Coil
  1BRF/1RWD                      94.3            2∶13 - KWVCKICGYIYD                              β-strand-turn- β-strand in crystal structure; isolated β-bridgein solution                            β-strand
                                                  43∶51 - APKSEFEKL                        Mix of β-bridge, 3~10~-helix and β-strand in crystal structure; unstructuredin solution                       α-helix
  9PTI/1OA5                      100                 3∶6 - DFCL                                           3~10~-helix in crystal structure; unstructured in solution                                       ND
  1RDG/1E8J                      100               18∶24 - GDPDSGI                         Mix of β-bridge, 3~10~-helix and β-bridge in crystal structure; unstructuredin solution                        Coil
                                                    30∶33 - FEDL                                          3~10~-helix in crystal structure; unstructured in solution                                       ND
                                                   44∶49 - ASKDAF                                 Mix of β-bridge, 3~10~-helix in crystal structure; unstructuredin solution                               ND

ND - Not Determined.

10.1371/journal.pone.0039993.t002

###### Structural variations in protein complexes.
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  *S. No.*    *PDB ID*                                *Region of structural variation*                                             *Structural manifestations* *in the variant region*                 *PSIPRED* *Prediction* *for variant* *region*    *Disopred Prediction* *(Residue numbers)*
  ---------- ----------- ------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------- ----------------------------------------------- ----------------------------------------------
  1           3HRY/3K33                               50--73: AALDAEFASLFDTLDSTNKELVNR                                      α-helix in complex, turns and coil inindividual protein structure                             α-helix                                         72--73
  2           3FII/1SFC                           27--57: TSNRRLQQTQAQVDEVVDIMRVNVDKVLERD                                   Largely unstructured in one complexand α-helix in another complex                             α-helix                                         28--36
  3           1N7S/1XTG                       167--204: MGNEIDTQNRQIDRIMEKADSNKTRIDEANQRATKMLG                                 α-helix in one complex and largelyunstructured in the other                                α-helix                              167--169, 171--173, 198, 204
  4           3C98/3HD7            189--248: KQALSEIETRHSEIIKLENSIRELHDMFMDMAMLVESQGEMIDRIEYNVEHAVDYVERAV              α-helix in one complex, unstructuredwith distorted helix in another complex                        α-helix                                        189, 248
  5           2GRX/1IHR                                164--182: PARAQALRIEGQVKVKFDV                                           α-helix, β-strand in complex,β-strand in individual protein                           α-helix, β-strand                                   164--168
                                                         221--235: GSGIVVNILFKINGT                                             Coil and β-strand in complex,β-strand in individual protein                               β-strand                                        221, 236
  6           2JKR/2BP5                                     316--325: LAQKIEVRIP                                                    β-strand in one complex, unstructuredin the other                                    β-strand                                        316--319
                                                         419--434: IKWVRYIGRSGIYETR                                                 β-strand in one complex, unstructuredin the other                                    β-strand                                        431--434
  7           1CDJ/1G9M                                     54--69: RADSRRSLWDQG                                                      α-helix in complex, turn in individualprotein                                       α-helix                                     58--59, 62--64
                                                              12--18: VELTCTA                                                        β-strand in individual protein, coilin complex                                      β-strand                                         12,18
  8           3B2V/1IVO                                    19--32: FEDHFLSLQRMFNN                                                    α-helix in one complex and unstructuredin other                                      α-helix                                         19,32
                                                               92--97: YALAVL                                                    β-strand in one complex and no electrondensity in other                                  α-helix                                           --
  9           1BGW/2RGR                630--682: LQGNDKDYIDLAFSKKKADDRKEWLRQYEPGTVLDPTLKEIPISDFINKELI                        α-helix in complex. Unstructured inindividual protein structure                              α-helix                                          634
  10          1K4S/1A36   633--710: QRAPPKTFEKSMMNLQTKIDAKKEQLADARRDLKSAKADAKVMKDAKTKKVVESKKKAVQRLEEQLMKLEVQATDREE                 α-helix in one complex and unstructuredin the other                                    α-helix                      633--636,639--640,669--687,700--701,703--710
  11          1SER/1SRY                 36--86: EVQELKKRLQEVQTERNQVAKRVPKAPPEEKEALIARGKALGEEAKRLEEA                            Unstructured in complex and α-helix inindividual structure                                 Α-helix                                       48, 50--69
  12          1HLO/1R05                                   12--27: ADKRAHHNALERKRRD                                   α-helix in the complex (crystal) andunstructured in the individual protein(NMR)                      α-helix                                         27-Dec
  13          1B70/1EIY   6--85: LAAIQNARDLEELKALKARYLGKKGLLTQEMKGLSALPLEERRKRGQELNAIKAALEAALEAREKALEEAALKEALERER                  α-helix in one complex and unstructuredin the other                                    α-helix                                           --
  14          1JYE/1EFA                                       5--13: TLYDVAEYA                                                    α-helix in complex, unstructured inindividual protein                                   α-helix                                           11
                                                             16--25: SYQTVSRVVN                                                   α-helix in complex, unstructured inindividual protein                            α-helix and β-strand                                   16--17
                                                          32--46: AKTREKVEAAMAELN                                                 α-helix in complex, unstructured inindividual protein                                   α-helix                                         32--37
  15          1D1U/1D0E                                  67--84: SQEARLGIKPHIQRLLDQ                                                  α-helix in one complex and unstructuredin other                                      α-helix                                     69--71, 83--84
                                                         99--114: LPVKKPGTNDYRPVQD                                                  α-helix in one complex, β-strand and coilin other                                      Coil                                          99--114
                                                   237--273: QQGTRALLQTLGNLGYRASAKKAQICQ                                          α-helix and coil in one complex, β-strandin the other                                   α-helix                                     238--241, 264
  16          1VS5/2QOU                                     19--30: SIVVAIERFVKH                                                  β-strand in one complex, mostlyunstructured in other                             β-strand and α-helix                                     \-
                                                           34--46: GKFIKRTTKLHVH                                                  β-strand in one complex, mostlyunstructured in other                                   β-strand                                     34--35, 45--46
                                                            57--67: VVEIRECRPLS                                                   β-strand in one complex, mostlyunstructured in other                                   β-strand                                           --

10.1371/journal.pone.0039993.t003

###### Conformational variation in peptide structures.
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  *Sl. No*    *Peptide PDB*       *Peptide sequence*       *Structural manifestation*       *PSIPRED result*        *Protein PDB*   *Identity(%)*   *Structural manifestation*
  ---------- --------------- ---------------------------- ---------------------------- --------------------------- --------------- --------------- ----------------------------
  1               1QWP               GSNKGAIIGLM                  80% α-helix                 63% β- strand            3MOQ(A)           100               63% β-strand
                                                                                                                       1HZ3(A)           100                   Coil
                                                                                                                       2BEG(A)           100               72% β-strand
                                                                                                                       1Z0Q(A)           100               45% α-helix
                                                                                                                       1IYT(A)           100                 α-helix
                                                                                                                       2WK3(C)           100                    --
                                                                                                                       2G47(C)           100                    --
                                                                                                                       1AML(A)           100               45% α-helix
                                                                                                                       1BA4(A)           100                 α-helix
                                                                                                                       2OTK(C)           100               72% β-strand
  2               1CFG          TRYLRIHPQSWVHQIALRMEVL            30% α-helix                                          3HNB(M)           100               80% β-strand
                                                                                                                       3HNY(M)           100               80% β-strand
                                                                                                                       3HOB(M)           100               80% β-strand
                                                                                                                       1D7P(M)           100               80% β-strand
                                                                                                                       3CDZ(B)           100               80% β-strand
                                                                                                                       2R7E(B)           100               30% β-strand
  3               1P5A         AVGIGALFLGFLGAAGSTMGARSX           25% α-helix                  58% α-helix             2ARI(A)           100                 α-helix
                                                                                                                       3ABI(A)           80             β-strand + α-helix
  4               1OMQ             RQIKIWFQNRRMKWKK               70% α-helix                 90% β-strand             1HOM(A)           100               80% α-helix
                                                                                                                       1AHD(P)           100                 α-helix
  5               1DVW            TLAVPGMTCAACPITVKK                  Coil                    66% β-strand             1AFI(A)           100         22% β-strand, 27%α-helix
                                                                                                                       1AFJ(A)           100         22% β-strand, 27%α-helix
                                                                                                                       2HQI(A)           100         22% β-strand, 27%α-helix
  6               1IBN           GLFGAIAGFIENGWEGMIDG             90% α-helix                  55% α-helix             3EYM(B)           100                   Coil
                                                                                                                       1MQL(B)           100                   Coil
                                                                                                                       1MQN(B)           100                   Coil
                                                                                                                       5HMG(B)           100                   Coil
                                                                                                                       3EYK(B)           90                    Coil
  7               1HZ3        YEVHHQKLVFFAEDVGSNKGAIIGLM              Coil                    80% β-strand             2BEG(A)           100              80% β- strand
                                                                                                                       1Z0Q(A)           100               80% α-helix
                                                                                                                       1IYT(A)           100                 a-helix
                                                                                                                       2WK3(C)           100               10% β-strand
                                                                                                                       3IFN(P)           100                    --
                                                                                                                       1AML(A)           100               50% α-helix
                                                                                                                       1BA4(A)           100               80% α-helix
                                                                                                                       2OTK(C)           100               80% β-strand
                                                                                                                       1AMB(A)           100               90% α-helix
  8               1XV7               FQWQRNIRKVRX                     Coil                                             1LFH(A)           91                  α-helix
                                                                                                                       1B0L(A)           91                  α-helix
  9               2BP4             DAEFRHDSGYEVHHQK               70% α-helix                 50% β-strand              2WK3             100                   Coil
                                                                                                                        1BA6             100                   Coil
                                                                                                                        1IYT             100               50% α-helix
  10              2RMV        GNDYEDRYYRENMARYPNQVYYRPVC              Coil              50% α-helix, 15% β-strand       3O79             96                73% α-helix
                                                                                                                        1XYW             96                73% α-helix
                                                                                                                        2KU4             96                45% α-helix

Variations between Solution and Crystal Structures {#s2b}
--------------------------------------------------

A comparison between crystal and NMR structures provides experimental evidence for conformational variation and sampling. In the all α family, most differences, although not all, between the solution and crystal structures could be rationalized to ligand binding. For example, the S100 protein has been structurally characterized in the Ca^2+^- free form (PDB: 1K9P), the Ca^2+^-bound form (PDB: 1K96) [@pone.0039993-Otterbein1] and in solution (PDB: 1A03) [@pone.0039993-Sastry1]. In the X-ray structure, the stretch proximal to the ligand binding site adopts a helical conformation in the crystal structure whereas it is unstructured in the NMR structure despite the presence of a bound Ca^2+^ cofactor. Another example of conformational change induced by ligand binding are the crystal (PDB: 1GU2) and solution structures (PDB: 1E8E) of the oxidized form of Cytochrome C that reveal structural differences closer to the heme binding pocket [@pone.0039993-Enguita1], [@pone.0039993-Brennan1]. These include a stretch I28--N36 (ITDGKIFFN) that adopts a helical conformation in the crystal structure while it is unstructured in solution. The segments A48--T54 (ACASCHT) and G61--I70 (GKNIVTGKEI) adopt α-helical and β-sheet conformation in the crystal structure as opposed to hydrogen bonded turns in solution. These structural variations are highlighted in [Figure 2A](#pone-0039993-g002){ref-type="fig"}.

![Representative examples of conformational variations.\
(**A**) All α class (**B**) All β class (**C**) α+β class (**D**) α/β class (**E**) Small proteins. A comprehensive list of these parameters is compiled in [Table 1](#pone-0039993-t001){ref-type="table"}.](pone.0039993.g002){#pone-0039993-g002}

Plastocyanins are a good example of structural differences in the β-class of proteins. The X-ray (2GIM) [@pone.0039993-Schmidt1] and solution structures (1FA4) [@pone.0039993-Ma1] of *Anabaena variabilis* plastocyanin differ in their secondary structural content ([Figure 2B](#pone-0039993-g002){ref-type="fig"}). β-strands are less structured in solution compared to crystal structures where they form extended β strands. Also, residues S52--S60 (SADLAKSLS) and E90--G96 (EPHRGAG) in the crystal structure from *A. variabilis* plastocyanin and the corresponding region in the *Phormidium laminosum* homologue (PDB: 2Q5B) are α-helical in the crystal structure while they remain unstructured in solution.

Three pilin crystal structures (α + β family in SCOP) exemplify variations in this structural class. The structural descriptions include *N. gonorrhoeae* strain MS11 pilin [@pone.0039993-Parge1], the truncated toxin-coregulated pilin from *V. cholerae* [@pone.0039993-Craig1] the *P. aeruginosa* strain K pilin [@pone.0039993-Audette1] and the ΔK122--4 pilin examined by NMR [@pone.0039993-Keizer1]. The ΔK122--4 crystal structure (PDB: 1QVE) exhibits a characteristic type IVa pilin fold, with the N-terminal α-helix (α1--C) packed onto a four-stranded antiparallel β-sheet. Although the relative positions of the core secondary structure elements are well-conserved among the crystal structures, they differ considerably between the crystal and NMR structure of ΔK122--4 pilin (PDB: 1HPW). Superposition of these structures shows that in the solution structure of ΔK122--4, the N-terminal α-helix A31--G55 (AQLSEAMTLASGLKTKVSDIFSQDG) is shifted by one turn and thus deflected away from the β-sheet [@pone.0039993-Audette1]. The C-terminal residues V78--A88 (VAKVTTGGTA) form a β-strand in the crystal structure whereas they are unstructured in solution ([Figure 2C](#pone-0039993-g002){ref-type="fig"}).

ADP-ribosylation factors (ARF-1) belong to the α/β family of proteins. Structural comparison in this case was made using four structural models viz., the GDP bound structure of human ARF-1 (1HUR), rat ARF-1 (1RRF) and human ARF-1 (1U81) [@pone.0039993-Seidel1]. A comparison between the crystal and solution structures reveals several changes. The region P76--N84 (PLWRHYFQN) is helical in solution NMR (1U81) but unstructured in the crystal structure. Other differences include regions M18--M22 (MRILM), V43--V53 (VTTIPTIGFNV) and T85--V92 (TQGLIFVV) which are β-strands in the crystal structures of these ARFs but are unstructured or adopt turns/bridges in solution. Similarly, R99--E113 (RVNEAREELMRMLAE) is a well defined α-helical stretch present in the crystal structure while in solution this stretch is a mix of a hydrogen bonded turn (R99--E102), a short helix (E102--L107) followed by another hydrogen bonded turn (M108--E113; [Figure 2D](#pone-0039993-g002){ref-type="fig"}). Another prominent example is that of Rubredoxin where the major difference between the X-Ray (PDB: 1BRF) [@pone.0039993-Bau1] and NMR structure (PDB: 1RWD) is the absence of β-strands in solution ([Figure 2E](#pone-0039993-g002){ref-type="fig"}).

Structural Variation Due to Conformational Restraints in a Larger Macromolecular Complex {#s2c}
----------------------------------------------------------------------------------------

An experimental construct that allows a recombinant protein to be purified in large amounts to homogeneity is a critical step towards structure determination. Important variables in this step include the length of the recombinant protein along with the choice of an affinity or solubilization tag. A particularly dramatic case of a change in the fold of a protein due to a change in the sequence-length is that of human PRP-8 D4 structure that has a different fold from that determined for a shorter D4 construct ([Figure 3A](#pone-0039993-g003){ref-type="fig"}). In the case of multi-protein complexes, co-expression and co-purification of interacting proteins often provides a viable route towards structural characterization. Protein-protein interactions often involve conformational changes that make the complex more stable and tractable for crystallization. These conformational changes can also be context-dependent. An example of this feature is Synaptobrevin, a part of the vesicle-associated membrane protein (VAMP) family that forms a component of the neuronal SNARE (soluble *N*-ethylmaleimide-sensitive factor attachment receptor) complex. The isolated solution structure of synaptobrevin is largely unfolded but is a well-defined helix in the SNARE complex [@pone.0039993-Hazzard1]. The structure of synaptobrevin (residues 27--57) in complex with Neurotoxin type F from *Clostridium botulinum* (3FII) [@pone.0039993-Agarwal1] shows a largely disordered segment with a small β-strand at the N terminus and a small α-helix at the C terminal end while the same segment is a helix in the neuronal synaptic fusion complex (PDB: 1SFC) [@pone.0039993-Sutton1]. A superposition of the two structures is shown in [Figure 3B](#pone-0039993-g003){ref-type="fig"}. A search for similar stretches in the PDB yielded several protein-complexes in which this sequence-stretch is an ordered α-helix. For example, synaptobrevin in the complexin-SNARE complex (PDB: 1KIL) [@pone.0039993-Chen1] shows a well defined α-helix similar to other SNARE complexes (PDB: 1N7S, 3HD7, 3IPD) [@pone.0039993-Ernst1]. Recombinant proteins of different sizes (based on different expression constructs) also influence secondary structural composition. For example, in the case of the catalytic domains of Protein Tyrosine Phosphatases (PTP), addition of an additional stretch of ca 45 residues substantially influences the solubility and propensity to crystallize. This stretch either adopts an α helical conformation or is involved in dimerization [@pone.0039993-Madan1]. Context-dependent conformational changes are more common in protein-nucleic acid complexes ([Figure 3C](#pone-0039993-g003){ref-type="fig"}). Indeed, successful structure determination of protein-nucleic acid complexes is often only possible in the presence of the interacting components ([Table 2](#pone-0039993-t002){ref-type="table"}).

![Conformational variations induced by interactions with proteins and nucleic acids.\
Structural differences in (**A**) human splicing protein Prp-8 (Full length and N-terminal deletion) variants. These structures illustrate sequence length-dependent structural changes. (**B**) & (**C**) depict structural changes in protein-protein and protein-nucleic acid complexes.](pone.0039993.g003){#pone-0039993-g003}

Peptide Structures Exemplify Conformational Selection {#s2d}
-----------------------------------------------------

Structural differences in peptide structures have been extensively examined in the case of the amyloid peptides and chameleon sequences [@pone.0039993-Baeten1], [@pone.0039993-Mezei1]. For instance, the NMR structure of an eleven residue peptide from the amyloid β A4 protein (PDB: 1QWP) adopts a α-helical conformation. The same sequence, however, variously adopts β-strand conformations (PDB: 3MOQ, 2BEG, 2OTK) [@pone.0039993-Streltsov1], [@pone.0039993-Luhrs1] α-helical segments (PDB: 1Z0Q, 1IYT, 1BA4, 1AML) [@pone.0039993-Tomaselli1] or coiled-coil conformations (PDB: 1HZ3) as a part of a larger protein sequence ([Figure 4A](#pone-0039993-g004){ref-type="fig"}; [Figure S1](#pone.0039993.s001){ref-type="supplementary-material"}). Another representative example is the NMR structure of a peptide from the C2 domain of Factor VIII (PDB: 1CFG) [@pone.0039993-Gilbert1] which is α-helical in isolation. The same sequence in the context of the entire C2 domain of Factor VIII (PDB: 3HNB, 3HNY, 3HOB, 1D7P, 3CDZ, 1IQD) [@pone.0039993-Liu1], [@pone.0039993-Pratt1], [@pone.0039993-Ngo1] adopts a β-strand conformation ([Figure 4B](#pone-0039993-g004){ref-type="fig"}). It is relevant to note in this context that the secondary structure prediction (using PSIPRED) [@pone.0039993-McGuffin1] for this peptide revealed a 22% β-strand and 63% α-helical structure.

![Structural variability in peptide sequences.\
(**A**) Context dependent conformational changes of a peptide from the amyloid β A4 protein (PDB: 1QWP) and (**B**) C2 domain of Factor VIII (PDB: 1CFG).](pone.0039993.g004){#pone-0039993-g004}

Limitations of Temperature Factor and CONCOORD Simulations to Examine Conformational Variation {#s2e}
----------------------------------------------------------------------------------------------

High B-factors, classical indicators for conformational variation or flexibility, are often ambiguous due to experimental limitations. A case for this observation is Synaptobrevin, a protein involved in two different complexes, one with Botulinum Neurotoxin (PDB: 3FII) and the other with SNARE complex proteins (PDB: 1SFC). In this case, the unstructured component (PDB: 3FII) showed slightly lower B-factor values as compared to the structured component (PDB: 1SFC). We stress here, however, that a vast majority of segments that show conformational variability in this dataset can be clearly flagged by virtue of high B factors in those stretches when compared with the rest of the protein. In these cases, alternate conformations are also easily identifiable by *in silico* methods. For example, in the Prevent-host-death (Phd) protein, the region 50--73 forms an α-helix when involved in a complex with the Death-on-curing (Doc) protein (PDB: 3K33) while it remains unstructured in isolation (3HRY). The temperature factors show a marked increase for 3HRY while in 3K33, where the protein is structured, the region has a B-factor that is below the average value for the protein. Consistent with this experimental data, this stretch in 3HRY shows high RMS fluctuation in a CONCOORD analysis that correlates well with changes in secondary structure conformations. The Dictionary of Secondary Structure Predictions (DSSP) output for the stretch in 3HRY shows a largely turn-dominated profile interspersed with 3~10~-helices, bends and alpha helices at several points of time in the simulation ([Figure 5](#pone-0039993-g005){ref-type="fig"}).

![*In silico* methods to extract dynamic information.\
CONCOORD and temperature factor analysis of Prevent host death protein (Phd: 3HRY) that shows a disordered-to-ordered conformational transition upon forming a complex with the Death on curing protein (Phd-Doc complex: 3K33). The grey bar represents the region in the Phd protein that undergoes structural change upon forming the Phd-Doc complex.](pone.0039993.g005){#pone-0039993-g005}

Comparison Between the Secondary Structure Propensity and Conformational Variations {#s2f}
-----------------------------------------------------------------------------------

The secondary structure propensity is highlighted in several cases of conformational differences between solution and crystal structure. For example, in the crystal structure (PDB: 1NZN) of the cytosolic domain of human mitochondrial fission protein Fis1, the region E5--S13 (EAVLNELVSVED) is α-helical whereas it is unstructured in solution (PDB: 1PC2). The PSIPRED prediction for this stretch is a α-helix. These results from the comparative analysis dataset of X-ray and NMR pairs are summarized in [Table 1](#pone-0039993-t001){ref-type="table"}. A comprehensive list of root-mean-square-deviations (RMSD) for this dataset is compiled in [Table S2](#pone.0039993.s003){ref-type="supplementary-material"}. This aspect of conformational selection is also seen in the case of multi-protein complexes. In the synaptosomal associated protein complexed with Botulinum Neurotoxin BONT/A (PDB: 1XTG), the region M167--G204 is unstructured. In the truncated neuronal SNARE complex (PDB: 1N7S), however, the stretch is helical, consistent with the secondary structure prediction. A summary of these observations, along with the output obtained from the DISOPRED [@pone.0039993-Ward1] predictions is compiled in [Table 2](#pone-0039993-t002){ref-type="table"}.

Effect of Experimental Conditions on Conformational Differences {#s2g}
---------------------------------------------------------------

The composition of a crystallization condition can influence the secondary structural composition of a protein and hence facilitate conformational selection. This analysis is compiled in [Tables S3](#pone.0039993.s004){ref-type="supplementary-material"} and [S4](#pone.0039993.s005){ref-type="supplementary-material"}. The compilation in [Table S3](#pone.0039993.s004){ref-type="supplementary-material"} suggests that polyethylene glycols (PEG; in the molecular range of 200--4000) are involved in the crystallization of ca 80% of the proteins in this dataset while a minority (ca 10%) of them have salts like ammonium sulphate. PEGs serve to aggregate protein molecules, often inducing secondary structural features, thus increasing the chance of crystallization [@pone.0039993-Tanaka1]. This observation perhaps rationalizes the finding that in the dataset of structural pairs (X-ray and NMR; [Table S3](#pone.0039993.s004){ref-type="supplementary-material"}), most of the crystal structures showed additional secondary structural elements than the corresponding solution structures. While an ideal comparison would have involved a pair of structural models (X-Ray/NMR) where the structure determination was performed under identical conditions, these are difficult to achieve due to divergent experimental requirements of mono-disperse solution behavior of a protein sample for NMR versus conditions that promote systematic aggregation to form crystals. Conformational selection, in the case of multi-protein complexes is also facilitated by crystallization agents. For example, the crystallization condition of the Prevent host death protein (3HRY) where the stretch 50--73 is unstructured contains Ethylene glycol and PEG 8000 as precipitants. Ethylene glycol is known to decrease α-helicity and its interaction with proteins is enhanced in the presence of high molecular weight PEG [@pone.0039993-Kumar1]. Hydrophobic interactions are known to increase with high salt concentrations [@pone.0039993-Morimoto1]. These interactions could have facilitated the folding of the stretch (L630--E710) in DNA Topoisomerase 2 (PDB: 2RGR) as the salt concentrations are much higher than the corresponding concentration in the structure without bound DNA (PDB: 1BGW). Perhaps coincidentally, an observation on the denaturation of β sheets at low pH [@pone.0039993-Lin1] also correlates with the structure of the T-cell surface glycoprotein CD4 (PDB: 1CDJ, 1G9M) which shows well-defined β-strands when compared to its structure in complex with two other proteins where it is unstructured. Representative cases of conformational changes induced by crystal packing effects are illustrated in [Figure S1](#pone.0039993.s001){ref-type="supplementary-material"}. It is, however, difficult to correlate crystallization conditions or the high protein concentration in an NMR experiment with the packing in a protein structure. This analysis is summarized in [Table S5](#pone.0039993.s006){ref-type="supplementary-material"}.

The packing fraction varies in the range of 0.66 to 0.84 [@pone.0039993-Fleming1]. The average packing density of proteins is about 0.75. Comparative studies of packing density and cavity analysis of similar NMR and crystal structures for all classes of proteins was performed using Voronoia [@pone.0039993-Rother1]. The grid level for all the input PDBs were adjusted to 0.2 for calculating the parameters. This analysis, however, did not yield new information, apart from confirming that NMR structures tend to have a slightly higher packing density when compared to crystal structures.

Discussion {#s3}
==========

Conformational changes in proteins often provide the first step to rationalize a functional role or to build a mechanistic hypothesis for a biological observation. Deducing conformational variations is thus an important step in functional annotation. This information is also crucial for structural models that form the basis for *in silico* modeling of homologous proteins or as fragments that are utilized for *de novo* structural prediction. An understated feature of currently available structural models is that they implicitly incorporate experimental conditions, limitations inherent to the method for structure determination and data as well as by the length of the recombinant protein construct. These limitations, in an extreme case, provide alternate structural models for an identical protein sequence. This was noted, most recently, in the case of the human PRP-8 D4 structure that has a different fold than that determined for a shorter D4 construct ([Figure 3A](#pone-0039993-g003){ref-type="fig"}) [@pone.0039993-Schellenberg1]. In this study, we examined representative structural models in the PDB for evidence of conformational selection or context-dependent modeling [@pone.0039993-Minor1], [@pone.0039993-Minor2]. The dataset for this analysis was spread across different structural families and multi-component (protein-protein and protein-nucleic acid) complexes. This diverse set of protein structures was evaluated for sequence features (secondary structure propensity, disorder) that could suggest alternate conformations. In particular, aspects such as a skewed distribution of highly fluctuating residues (G, A, S, P, D) over weakly fluctuating residues (I, L, M, Y, F, W, H) in irregular structural elements (loops), chameleon sequences and intrinsically disordered proteins [@pone.0039993-Plaxco1], [@pone.0039993-Wright1] were examined. The next step involved an examination of context dependent structural variations that could be ascribed to experimental conditions, packing, or induction of secondary structure by binding to cognate partners. The result of this analysis is compiled in [Figure 6](#pone-0039993-g006){ref-type="fig"} and [Figure S1](#pone.0039993.s001){ref-type="supplementary-material"}. This analysis suggests that methods to de-convolute dynamic information are better served by incorporating both sequence features (for example, disorder propensity, ambivalent secondary structures and chameleonic sequences) and experimental conditions that nucleate or aid conformational selection.

![Summary of the potential cause of variations in protein structural models.\
This data is based on information presented in [Tables 1](#pone-0039993-t001){ref-type="table"}--[3](#pone-0039993-t003){ref-type="table"}. The abbreviations used here are- psipred score: differences between predicted and observed secondary structure; Disorder promoting residues, Chameleon sequences: Classification based on aminoacid composition; Salt, pH, PEG: Effects of ionic strength, pH, high concentration of polyethylene glycol; Packing induced, Technique/Resolution: Differences between solution and crystal structural models.](pone.0039993.g006){#pone-0039993-g006}

Static structural models, such as those obtained from single crystal X-Ray diffraction methods, incorporate dynamic information at multiple layers. B-factors and ligand induced displacements provide an insight into potential conformational changes and conformational sampling. The so-called consensus structures that involve different levels of structural overlap in multiple crystal structures have been proposed as a route to obtain dynamic information that is otherwise not evident from single crystal structural models. An alternative approach involves diffuse scattering that originates from fluctuations in the average electron density and appears as a background on an X-ray film. This analysis, however, requires ultra high resolution structures as the higher order scattering makes a significant contribution at high resolutions. Furthermore, these studies also require robust scaling between the vibrational density of states to make a comparison between experimental and theoretical temperature factors. The data-set utilized in this manuscript was compiled with the aim of having protein structural models determined using different experimental methods. This data-set does not contain crystal structures of the resolution required to analyze diffuse scattering. In an effort to examine if potential conformational variants could be deduced from a given crystal structure, we performed an analysis using CONCOORD [@pone.0039993-deGroot1]. A significant number of outliers, however, suggest that both normal modes and CONCOORD analysis, the preferred route to examine structural variations in the absence of detailed MD simulations, are inadequate ([Figure 5](#pone-0039993-g005){ref-type="fig"}). Do conformational differences actually depict characteristics similar to those of the so-called chameleon sequences? The sequence analyses presented in [Table 3](#pone-0039993-t003){ref-type="table"} broadly support that perspective. The sequence composition also suggests more scope for residue fluctuations [@pone.0039993-Ruvinsky1] supporting the view that structural models represent conformational selection influenced by experimental conditions.

Put together, this analysis suggests that experimental conditions substantially influence conformational selection. The experimentally determined structural model, that is the template for *in silico* methods to derive dynamic information, can thus bias interpretations on conformational variation and dynamics. This study presents a case for a more comprehensive inclusion of physico-chemical parameters associated with experimental conditions in the interpretation of protein structural data. This analysis also emphasizes the need to incorporate information on chameleon sequences in protein structural models while inferring dynamic properties of proteins.

Methods {#s4}
=======

Dataset of Structures Used in this Analysis {#s4a}
-------------------------------------------

A compilation of protein structures was initially based on the SCOP (1.73 version) database. Upon the identification of candidate structural models, an advanced search in PDB was performed to obtain the corresponding protein structure determined either in solution by NMR or as a part of a larger macromolecular complex. The following criteria were used to obtain the dataset for this analysis- i. Resolution cut-off for the X-ray crystal structures was set at 3.00 Å (3.9 Å in complexes) and ii. Only structures with a minimum overall sequence identity of 30% in a pair-wise alignment were selected. For this purpose, the EMBOSS Align program was used. PyMOL was used for the superposition of the structure pairs. The dataset of protein structural pairs had a total of 31 pairs of structures, belonging to five SCOP classes. The dataset for disordered proteins was collated from DISPROT [@pone.0039993-Sickmeier1]. The homologues for the disordered proteins for which PDB files were available were compiled from the PDB. The dataset for peptide structures were obtained from the PRF database within the DBGET integrated database retrieval system. In this search, the peptide length was limited to 10--40 amino acids. 110 peptide structures that contained only naturally-occurring amino acids were chosen for the study. Based on the availability of comparable sequences within large protein structures, a dataset of 45 peptide structures were compiled.

RMSD Calculation, Temperature Factor and Normal Mode Analysis {#s4b}
-------------------------------------------------------------

The root mean square deviation (RMSD) was calculated between one X-ray crystallographic structure and the average structure from the NMR ensemble using LSQMAN [@pone.0039993-Kleywegt1]. The average of that RMSD was taken for further analysis as the deviation between the two representative proteins. The ensemble average for the NMR structure was calculated using MOLMOL [@pone.0039993-Koradi1]. The B-factor analysis was also performed on all the X-ray structures in the database presented in this work. Packing densities and cavities of the protein molecules for each structure in the dataset were calculated using *Voronoia* [@pone.0039993-Rother1]. In this method, packing density is defined by the equation: PD  =  V~vdw~/(V~vdw~+ V~se~) where V~vdw~ is the assigned atomic volume inside the atoms' Van der Waals radius and V~se~ is the remaining solvent excluded volume. Only monomers of each structure were used for calculating the packing parameters while an averaged structure was used for calculating values in the case of solution NMR. A grid level of 0.2 was assigned for calculating the packing densities and cavity in each structure. Water molecules were removed from the coordinate files and only monomer structures were considered for calculations.

Analysis of Conformational Dynamics {#s4c}
-----------------------------------

Along with the crystal structures, we also used CONCOORD (from CONstraints to COORDinates) tool [@pone.0039993-deGroot1] to predict and analyze the likely motion(s) of the segments/motifs in proteins in our dataset. All the simulations were performed for 1000 ps using the default parameters to generate 1000 conformations. The trajectory analysis of the region of differences during the course of simulations was performed using the RMSF (root mean square fluctuation) plots of the residues during the simulation period. Changes in secondary structure were analyzed using DSSP [@pone.0039993-Kabsch1].

Sequence Analysis of the Regions of Conformational Change {#s4d}
---------------------------------------------------------

The peptide segments that show conformational differences between X-Ray and NMR structures as well as protein complexes were used as a template to search for similar sequences using BLAST (Basic Local Alignment Search Tool) [@pone.0039993-Altschul1]. Cut-off values for sequence identity were set at 80% with the template segment. The secondary structure propensities of the protein sequences in this dataset were determined using PSIPRED [@pone.0039993-McGuffin1]. In case of disordered proteins, sequence analysis were performed both using PSIPRED and DISOPRED [@pone.0039993-Ward1].
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